Ingunn Holen

9.6k total citations · 1 hit paper
139 papers, 7.0k citations indexed

About

Ingunn Holen is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ingunn Holen has authored 139 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Oncology, 52 papers in Molecular Biology and 33 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ingunn Holen's work include Bone health and treatments (84 papers), Radiopharmaceutical Chemistry and Applications (32 papers) and Bone Metabolism and Diseases (28 papers). Ingunn Holen is often cited by papers focused on Bone health and treatments (84 papers), Radiopharmaceutical Chemistry and Applications (32 papers) and Bone Metabolism and Diseases (28 papers). Ingunn Holen collaborates with scholars based in United Kingdom, Norway and Australia. Ingunn Holen's co-authors include Robert E. Coleman, Penelope D. Ottewell, Per O. Seglen, Paul B. Gordon, Colby L. Eaton, Peter I. Croucher, Helen Neville-Webbe, Diane V. Lefley, Nicola J. Brown and Hannah K. Brown and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Physiological Reviews.

In The Last Decade

Ingunn Holen

138 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bone metastasis: mechanisms, therapies, and biomarkers

2020 243 citations Penelope D. Ottewell, Ingunn Holen et al. profile →

Peers

Countries citing papers authored by Ingunn Holen

Since Specialization

Citations

This map shows the geographic impact of Ingunn Holen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingunn Holen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingunn Holen more than expected).

Fields of papers citing papers by Ingunn Holen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingunn Holen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingunn Holen. The network helps show where Ingunn Holen may publish in the future.

Co-authorship network of co-authors of Ingunn Holen

This figure shows the co-authorship network connecting the top 25 collaborators of Ingunn Holen. A scholar is included among the top collaborators of Ingunn Holen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingunn Holen. Ingunn Holen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Atomic force microscopy reveals the mechanical properties of breast cancer bone metastases 2021 ·Nanoscale ·Xinyue Chen, Russell Hughes, Nic Mullin, Raymond J. Hawkins, Ingunn Holen, Nicola J. Brown, Jamie K. Hobbs	15
2	Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment 2019 ·Clinical Cancer Research ·Claudia Tulotta, Diane V. Lefley, (unknown), Walter M. Gregory, Andrew M. Hanby, Paul R. Heath, Faith Nutter, J. Mark Wilkinson, (unknown), Xinming Liu, Steven M.J. Bradbury, (unknown), Victoria Cookson, (unknown), Marianna Kruithof‐de Julio, Robert E. Coleman, Janet E. Brown, Ingunn Holen, Penelope D. Ottewell	136
3	The bone metastasis niche in breast cancer: potential overlap with the haematopoietic stem cell niche in vivo 2019 ·Journal of bone oncology ·(unknown), Russell Hughes, Ning Wang, Hannah K. Brown, Penelope D. Ottewell, Nicola J. Brown, Ingunn Holen	57
4	Modulating Bone Marrow Hematopoietic Lineage Potential to Prevent Bone Metastasis in Breast Cancer 2018 ·Cancer Research ·Jessalyn M. Ubellacker, Ninib Baryawno, Nicolas Sévère, Molly J. DeCristo, Jaclyn Sceneay, John N. Hutchinson, Marie‐Therese Haider, Catherine Rhee, Yuanbo Qin, Walter M. Gregory, Ana C. Garrido-Castro, Ingunn Holen, Janet E. Brown, Robert E. Coleman, David T. Scadden, Sandra S. McAllister	23
5	In vivomodels in breast cancer research: progress, challenges and future directions 2017 ·Disease Models & Mechanisms ·Ingunn Holen, Valerie Speirs, Bethny Morrissey, Karen Blyth	135
6	The endocrine influence on the bone microenvironment in early breast cancer 2016 ·Endocrine Related Cancer ·Caroline Wilson, Hannah Brown, Ingunn Holen	8
7	Rapid modification of the bone microenvironment following short-term treatment with Cabozantinib in vivo 2015 ·Bone ·Marie‐Therese Haider, Keith D. Hunter, Simon P. Robinson, (unknown), Eva Corey, T. Neil Dear, Russell Hughes, Nicola J. Brown, Ingunn Holen	33
8	The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer 2015 ·Journal of Experimental & Clinical Cancer Research ·Ning Wang, Kimberley J. Reeves, Hannah K. Brown, (unknown), (unknown), Penelope D. Ottewell, Peter I. Croucher, Ingunn Holen, Colby L. Eaton	46
9	Zoledronic Acid Has Differential Antitumor Activity in the Pre- and Postmenopausal Bone Microenvironment In Vivo 2014 ·Clinical Cancer Research ·Penelope D. Ottewell, Ning Wang, Hannah K. Brown, (unknown), (unknown), Peter I. Croucher, Colby L. Eaton, Ingunn Holen	131
10	Microvascular Endothelial Cell Responses in vitro and in vivo: Modulation by Zoledronic Acid and Paclitaxel? 2010 ·Journal of Vascular Research ·Maria Michailidou, Hannah K. Brown, Diane V. Lefley, (unknown), Simon S. Cross, Robert E. Coleman, Nicola J. Brown, Ingunn Holen	36
11	Combined Therapies of Bone Disease with Bisphosphonates 2010 ·Current Pharmaceutical Design ·(unknown), Penelope D. Ottewell, Ingunn Holen	9
12	Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway 2009 ·Journal of Cellular and Molecular Medicine ·Marta Coscia, Elena Quaglino, Manuela Iezzi, Claudia Curcio, Francesca Pantaleoni, Chiara Riganti, Ingunn Holen, Hannu Mönkkönen, Mario Boccadoro, Guido Forni, Piero Musiani, Amalia Bosìa, Federica Cavallo, Massimo Massaia	220
13	The kinetochore protein Cenp-F is a potential novel target for zoledronic acid in breast cancer cells 2009 ·Journal of Cellular and Molecular Medicine ·Hannah K. Brown, Penelope D. Ottewell, Robert E. Coleman, Ingunn Holen	25
14	Expression of receptor activator of nuclear factor κβ ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables 2006 ·Journal of Clinical Pathology ·Simon S. Cross, Robert F. Harrison, Sabapathy P. Balasubramanian, J M Lippitt, Caroline A. Evans, Malcolm Reed, Ingunn Holen	51
15	Osteoprotegerin (OPG)—a potential new role in the regulation of endothelialcell phenotype and tumour angiogenesis? 2005 ·International Journal of Cancer ·Simon S. Cross, Zhiyong Yang, Nicola J. Brown, Sabapathy P. Balasubramanian, (unknown), Julia K. L. Woodward, Helen Neville-Webbe, Jenny M. Lippitt, Malcolm Reed, Robert E. Coleman, Ingunn Holen	93
16	Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients 2004 ·Journal of Bone and Mineral Research ·Colby L. Eaton, (unknown), Ingunn Holen, Peter I. Croucher, Freddie C. Hamdy	1
17	OPG is a survival factor for breast- and prostate cancer cells in vitro 2002 ·Bone ·Ingunn Holen, Peter I. Croucher, Anthony C. Evans, J M Lippitt, Freddie C. Hamdy, RE Coleman, Colby L. Eaton	1
18	Myeloma cells isolated from patients with multiple myeloma express osteoprotegerin ligand. 2000 ·Journal of Bone and Mineral Research ·C M Shipman, Ingunn Holen, J M Lippitt, (unknown), Peter I. Croucher	2
19	Tumour cells isolated from patients with multiple myeloma express the critical osteoclastogenic factor, RANKL. 2000 ·Blood ·C M Shipman, Ingunn Holen, J M Lippitt, Elisabeth Vandenberghe, Peter I. Croucher	13
20	Non-selective autophagy. 1990 ·PubMed ·Per O. Seglen, Paul B. Gordon, Ingunn Holen	96

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact